Your browser doesn't support javascript.
loading
Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers.
Haugen, Mads H; Lingjærde, Ole Christian; Hedenfalk, Ingrid; Garred, Øystein; Borgen, Elin; Loman, Niklas; Hatschek, Thomas; Børresen-Dale, Anne-Lise; Naume, Bjørn; Mills, Gordon B; Mælandsmo, Gunhild M; Engebraaten, Olav.
Afiliação
  • Haugen MH; Department of Tumor Biology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Lingjærde OC; Department of Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Hedenfalk I; Department of Informatics-Biomedical Informatics, University of Oslo, Oslo, Norway.
  • Garred Ø; K.G. Jebsen-Centre for B Cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
  • Borgen E; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden.
  • Loman N; Division of Laboratory Medicine-Pathology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Hatschek T; Division of Laboratory Medicine-Pathology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Børresen-Dale AL; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden.
  • Naume B; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Skåne, Sweden.
  • Mills GB; Department of Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden.
  • Mælandsmo GM; Department of Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Engebraaten O; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
JCO Precis Oncol ; 52021.
Article em En | MEDLINE | ID: mdl-34036235
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadjuvante / Bevacizumab / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadjuvante / Bevacizumab / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article